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Introduction: Systemic Epstein-Barr virus-positive T-cell lymphoproliferative childhood disease is an extremely rare
disorder and classically arises following primary acute or chronic active Epstein-Barr virus infection. It is characterized
by clonal proliferation of Epstein-Barr virus-infected T-cells with an activated cytotoxic phenotype. This disease has
a rapid clinical course and is more frequent in Asia and South America, with relatively few cases being reported in
Western countries. The clinical and pathological features of the disease overlap with other conditions including
infectious mononucleosis, chronic active Epstein-Barr virus infection, hemophagocytic lymphohistiocytosis and
natural killer cell malignancies. We describe the rare case of systemic Epstein-Barr virus-positive T-cell lymphoproliferative
childhood disease in a 16-year-old Malay boy.
Case presentation: He presented with a six-month history of fever and cough, with pulmonary and mediastinal
lymphadenopathy and severe pancytopenia. Medium- to large-sized, CD8+ and Epstein-Barr virus-encoded
RNA-positive atypical lymphoid cells were present in the bone marrow aspirate. He subsequently developed
fatal virus-associated hemophagocytic syndrome and died due to sepsis and multiorgan failure.
Conclusions: Although systemic Epstein-Barr virus-positive T-cell lymphoproliferative childhood disease is a
disorder which is rarely encountered in clinical practice, our case report underlines the importance of a comprehensive
diagnostic approach in the management of this disease. A high level of awareness of the disease throughout
the diagnosis process for young patients who present with systemic illness and hemophagocytic syndrome may
be of great help for the clinical diagnosis of this disease.
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Epstein-Barr virus (EBV) infection is asymptomatic in
more than 90% of humans. However, in a minority, the
infection is associated with a number of malignancies
involving B cells, T cells, natural killer (NK) cells and
epithelial cells [1].
EBV is considered to be an oncogenic virus and
belongs to the herpes virus family. EBV infection is fre-
quently associated with various lymphoproliferative dis-
orders (LPDs). The relative frequency of LPDs, clinical
presentation and EBV-positivity in different histological
subtypes in immunocompetent hosts were found to vary* Correspondence: noraidah@ppukm.ukm.edu.my
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unless otherwise stated.in different geographical areas. This variation may be as-
cribed to genetic and environmental etiologic factors [2].
Hodgkin’s lymphoma (HD) and infectious mononucle-
osis are the most common EBV-associated diseases in
Western countries, whereas in Asian and Latin American
countries other EBV-associated LPDs, mainly those associ-
ated with T lymphocytes or natural killer (NK) cells, are
more prevalent [2].
Different terms are assigned to EBV-associated T- or
NK-cell LPDs based on their clinical findings and the
immunophenotype of the proliferating cells. Some of
these terms include T- or NK-cell-type chronic active EBV
(CAEBV) infection, systemic EBV-positive T-cell lympho-
proliferative childhood disease, hydroa vacciniforme-like
lymphoma, aggressive NK-cell leukemia (ANKL), nasal
type NK- or T-cell lymphomas, extranodal NK- or T-celltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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EBV in B cells).
A newly recognized EBV-associated malignancy is the
systemic EBV-positive T-cell lymphoproliferative childhood
disease. It is characterized by a life-threatening illness of
children and young adults with clonal proliferation of EBV-
infected T cells with an activated cytotoxic phenotype. It
can develop either after primary EBV infection or related to
chronic active EBV infection (CAEBV) [3].
These neoplastic T cells are usually small and lack sig-
nificant cytological atypia. However, cases with pleo-
morphic medium- to large-sized lymphoid cells with
irregular nuclei and frequent mitoses have been described.
The most common typical phenotypes are CD2+, CD3+,
CD56- and TIA+. Most of the cases that are secondary to
primary EBV infection are CD8+, while the forms that
occur in the setting of severe CAEBV are CD4+. Neoplas-
tic cells have monoclonally rearranged T-cell receptor
(TCR) genes, and consistent Epstein-Barr virus-encoded
RNA (EBER)-positivity at in situ hybridization (ISH) [4].
In this report, we describe the clinicopathological find-
ings of a fulminant systemic EBV-positive T-cell lympho-
proliferative childhood disease in a 16-year-old Malay
boy who, to the best of our knowledge, represents the
first reported case of this disease in Malaysia.Case presentation
A 16-year-old Malay boy first presented with a history of
non-productive cough and persistent fever for the past
month. There was no associated weight loss, loss of
appetite or other significant clinical findings at initial
presentation. The family history was unremarkable. The
fever was resistant to conventional therapies, and serial
investigations could not determine the source of the sus-
pected infection. He was hospitalized at three different
governmental and private hospitals during the first three
months and eventually, when a computed tomography
(CT) scan of the thorax was performed, a solitary nodule at
the base of left lung, measuring 12×11mm, was detected.
He was empirically treated for tuberculosis (ethambutol,
isoniazid, rifampicin and pyrazinamide) but showed no sign
of improvement after one month. He declined a CT-guided
biopsy of the lung nodule and tuberculosis treatment was
continued for three months. After one month of treatment
he developed pancytopenia but declined a bone marrow
biopsy. A subsequent CT scan of the thorax and abdo-
men (four months after the first admission) showed fur-
ther enlargement of the lung nodule (32×31mm) with
multiple new lesions appearing in both lungs, measuring
between 5 and 11mm in diameter. In addition, there was
an anterior mediastinal mass measuring 26×46×40mm. At
this point a hematological malignancy or severe fungal in-
fection was suspected.He refused medical advice and discharged himself from
the hospital with no further treatment. Two months later
he was readmitted with persistent fever and diarrhea, at
which point he was referred to our institution for further
management. He was found to be dehydrated and cachec-
tic. His lung sounds were reduced basally on auscultation
with bilateral crepitations. A hepatosplenomegaly was
observed in the physical examination but no lymph-
adenopathy was found. A full blood picture showed se-
vere pancytopenia with a hemoglobin level of 5.1g/dL,
a total white blood cell count of 0.6×109/L (neutrophils
0.1×109/L and lymphocytes 0.5×109/L) and platelet
count of 57×109/L. His lactate dehydrogenase (LDH) was
elevated (550U/mg) and his blood culture, rheumatoid fac-
tor, antinuclear antibody, leptospirosis serology, blood film
for malaria parasite and Monospot tests were negative for
EBV. A repeat CT scan revealed similar lung and medias-
tinal lesions as well as hepatosplenomegaly and right iliac
lymphadenopathy.
A bone marrow biopsy was performed. The aspirate
showed several clusters of abnormal lymphoid cells and
hemophagocytic activity but assessment was limited due
to hemodilution. Accordingly, he underwent treatment
for hemophagocytic lymphohistiocytosis (HLH) (with un-
known cause) based on the HLH-2004 protocol. This pro-
tocole was developed by the treatment protocol of the
second international HLH study 2004 [5]. Immunopheno-
typing of the atypical lymphoid cells by flow cytometry was
inconclusive due to suboptimum aspirate sampling. The
trephine biopsy was hypocellular with a marked reduction
of normal hematopoietic elements. This was replaced by
scattered medium- to large-sized malignant lymphoid cells.
The cells were moderately pleomorphic with a kidney-
shaped nuclei, irregular nuclear membrane and prominent
nucleoli (Figure 1). Occasional mitotic figures, including ab-
normal forms and hemophagocytosis, were also noted. It
was revealed upon immunohistochemistry that the atypical
lymphoid cells expressed CD3, CD2 and CD4 positivity
(Figure 1). A few atypical cells were also positive for CD8.
The malignant cells were negative for CD20, CD56 and
ALK1 (Figure 1). Ki-67 immunostaining highlighted an
increased proliferative rate in the malignant cells. In situ
hybridization for EBV encoded RNA (EBER) demonstrated
EBV-positive atypical lymphoid cells (Figure 1). Therefore a
diagnosis of systemic EBV-positive T-cell lymphoprolifera-
tive childhood disease was made.
Unfortunately his health status rapidly deteriorated
and he developed multiorgan failure, including oliguric
acute renal failure, pericarditis, acute hepatitis and dis-
seminated intravascular coagulation. He subsequently
presented with generalized tonic-clonic seizures and a
further CT scan revealed an acute left frontal subarach-
noid haemorrhage. He died 15 days after admission to
our center.
Figure 1 Systemic Epstein-Barr virus-positive T-cell lymphoproliferative childhood disease: bone marrow biopsy. A: Hematoxylin and
eosin (H&E) sections illustrate the medium-sized lymphoid cells replacing the normal hematopoietic elements and exhibiting moderate atypia
with irregular kidney-shaped nuclei, dispersed chromatin and distinct nucleoli (100x, 400x and 600x respectively left to right). Hemophagocytosis
is also easily seen (inset). B: An immunohistochemical study shows that the majority of infiltrated atypical lymphocytes expressed CD2+ and CD4
+ with scattered positivity to CD8. C. The atypical lymphoid cells are not immunoreactive to CD20 and there is a paucity of B cells in the bone
marrow. Ki-67 immunostaining shows a high proliferative index and EBV-encoded RNA (EBER) by in situ hybridization demonstrates a strong
reactivity of atypical lymphoid cells.
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Two major types of Epstein-Barr (EBV) associated T-cell
lymphoproliferative disorders have been reported in the
pediatric age group. Both types have higher frequency in
Asians and Native Americans (Central and South Amer-
ica and Mexico) [4]. Hydro vacciniforme-like lymphoma
is a cutaneous malignancy which presents with a papulo-
vesicular eruption in sun-exposed skin. This disease is asso-
ciated with ulceration and an indolent clinical course which
usually progresses over time. Systemic EBV-positive T-cell
lymphoproliferative childhood disease may occur shortly
after primary acute EBV infection or in the setting of
chronic active EBV infection (CAEBV). It has a rapid pro-
gression and can result in multiple organ failure, sepsis and
death within days to weeks [4].
In normal individuals, primary EBV infection of B cells
causes B-cell proliferation and a robust cytotoxic T-cell
response that explains the lymphadenopathy, spleno-
megaly and circulating atypical CD8+ T cells, which are
characteristic of infectious mononucleosis. The emer-
gence of EBV-specific cytotoxic T cells suppresses the
proliferative effects of EBV, and the virus persists in adormant form in resting memory B cells of normal carriers.
When functioning EBV-specific cytotoxic T cells cannot
be generated, T cells become infected by the virus and
therefore fatal infectious mononucleosis or CAEBV occurs.
EBV-positive T cells may also clonally expand and develop
an overt T-cell lymphoma [6].
Several clinical disorders have overlapping features with
systemic EBV-positive T-cell lymphoproliferative childhood
disease and are now incorporated into the latter according
to the revised 2008 World Health Organization (WHO)
classification [4]. These include EBV-associated hemo-
phagocytic syndrome, fatal infectious mononucleosis,
viral-associated hemophagocytic syndrome, severe CAEBV,
EBV-associated T- or NK-cell LPD, and fulminant EBV-
associated T-cell lymphoproliferative disorder after acute or
chronic EBV infection [7]. The WHO classification (2008)
requires evidence of systemic illness and T-cell monoclon-
ality for the diagnosis of systemic EBV-positive T-cell
lymphoproliferative childhood disease [6].
The T-cell proliferation in systemic EBV-positive T-cell
lymphoproliferative childhood disease is monoclonal. Not-
ably, CD8+ is seen in cases arising following primary EBV
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CAEBV are CD4+. Co-expression of CD4 and CD8, as
shown in our case report, has been previously reported [7].
Interestingly, the relative paucity of B cells is a consist-
ent bone marrow finding in systemic the disease, which
is contrary to the frequent mature B cells and B-cell pre-
cursors in normal pediatric bone marrow. The presence
of an EBV-positive T-cell infiltrate with a paucity of B
cells, as seen in this case, may serve as a clue to the
diagnosis of systemic EBV-positive T-cell lymphoprolif-
erative childhood disease [6].
The differential diagnosis of systemic EBV-positive
T-cell lymphoproliferative childhood disease includes
primarily extranodal NK- or T-cell lymphoma, nasal-
type (NKTCL-NT), aggressive NK-cell leukemia and ful-
minant infectious mononucleosis. The distinguishing
clinical presentation is the immunophenotype as well as
the identification of clonal TCR gene rearrangement
which can differentiate this disorder from NKTCL-NT.
NK-cell leukemia and systemic EBV-positive T-cell lym-
phoproliferative childhood disease have many common
clinicopathologic features, but unlike the EBV-positive
T-cell lymphoproliferative childhood disease, NK-cell
leukemia is not preceded by primary EBV infection or
CAEBV, and the TCR gene is in the germ line configur-
ation. Although it might be difficult to differentiate ful-
minant infectious mononucleosis from systemic EBV-
positive T-cell lymphoproliferative childhood disease due
to the overlapping clinical and morphologic features,
EBV-positive T-cell lymphoproliferative childhood dis-
ease is characterized by a polyclonal EBV-positive B-cell
proliferation with a predominance of immunoblasts and
plasma cells [7].
Our review of previously reported cases of acute T-cell
LPD following primary infection with EBV showed that
most of the reported cases were from Asia [4]. It has
been hypothesized that the high prevalence of EBV-
positive T-cell lymphoproliferative childhood disease
among Asians and Mexicans may be due to a genetically
determined susceptibility due to the existence of certain
human leukocyte antigen (HLA) types which result in an
abnormal response to EBV infection [8].
In a study by Yoshii et al. 17 cases of systemic EBV-
positive T-cell lymphoproliferative childhood disease fol-
lowing acute EBV infection were reviewed [9]. They
found a higher incidence of the disease in boys (boy to
girl ratio, 11:6), as opposed to the recent WHO 2008
classification which reported no such predisposition [4].
The patient in our case report was a boy, in agreement
with the findings of Yoshii et al. [9].
Prolonged fever of unknown origin preceding the diag-
nosis is a characteristic clinical finding. As observed in
this case, the accompanied cough resulted in an initial
error in diagnosis and treatment for tuberculosis. Theunderling cause of cough in this case could be due to
lung and mediastinal masses that were noted in the CT
scan. In all previously reported cases, the clinical behav-
iour was aggressive and showed poor response to inten-
sive chemotherapy and supportive care. Death usually
occurs between days and 13 months (mean, 33 days) of
initial diagnosis [8]. In this case, death occurred six
months after presentation. Sepsis and multiorgan failure
were reported to be the most frequent causes of death,
which is similar to the case presented here [5,7,8].
The liver and spleen are the most common sites of in-
volvement, followed by lymph nodes, bone marrow, skin
and lung [4]. Our patient presented with lung mass and
mediastinal lymphadenopathy but unfortunately, a biopsy
from lung and mediastinal lesions was not performed be-
cause of family refusal.
A relatively common finding in most of the patients in
previous reports was the lack of elevated antibody titers or,
in some cases, the total absence of serologic responses to
EBV. In this case, a serologic study for EBV was not per-
formed due to a lack of suspicion of EBV during the diag-
nosis process. EBV serology may be clinically misleading
since it does not suggest acute primary or active infection.
This apparent lack of humoral response to the virus may
increase the risk of T-cell infection and subsequent mono-
clonal expansion [9].
Patients with hemophagocytic syndrome were shown
to have elevated levels of cytokines in the serum [10].
The released cytokine causes the clinicopathological
manifestations of the hemophagocytic syndrome, as was
seen in our patient. The sources of cytokines may be ac-
tivated T cells or macrophages [10].
No effective treatment has been suggested for systemic
EBV-positive T-cell lymphoproliferative childhood disease
although antiviral therapy, immunosuppressive agents
and chemotherapy can delay disease progression. A
hematopoietic stem-cell transplant is the only curative
option.
Conclusions
In summary, we reviewed the clinicopathological features
of systemic EBV-positive T cell lymphoproliferative child-
hood disease following acute EBV infection to facilitate our
diagnosis. Our case report implies that clinical awareness of
the disease, accompanied with an immunohistochemical
study and EBER in situ hybridization could be useful for
diagnosis of the disease in developing countries where mo-
lecular studies are not necessarily available.
Although no specific treatment is available at present,
prompt attempts to control the hemophagocytic syn-
drome and rapid administration of anti-Epstein-Barr
virus treatment are recommended.
Since the clinical progression of systemic EBV-positive
T-cell lymphoproliferative childhood disease is aggressive,
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ing early and accurate diagnostic and therapeutic strategies
for this disease.
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